Not too long ago, cannabis was just the feel-good supplement of choice for a young generation, looking to blow off steam. But intense research on the plant has led to new discoveries. Today, cannabis is used not only to blow off some steam, but to treat diseases which effect the immune system, pain and inflammation, seizures and even mental disorders. Mentioned in today’s commentary includes: Supreme Cannabis (OTCQX:SPRWF) (TSX:FIRE), Auxly Cannabis (OTCQX:CBWTF) (TSX-V:XLY), Constellation Brands (NYSE:STZ), Emerald Health Therapuetics (OTCQX:EMHTF) (TSX-V:EMH), MedMen Enterprises (OTCQX:MMNFF) (CSE:MMEN).
The cannabis sector continues its steady shift toward big business and big money, with much of growth based on acquisitions, agreements and consistent research.
Skepticism has been squashed and all apprehension eliminated. There’s no longer any question about either the viability or the profitability of the newly respected cannabis sector. Huge money has already been made in the nascent industry, and the only real question left is: where’s the next super nova?
The cannabis marketplace is growing in every way every day. More dispensaries, more acres under cultivation, more products being ‘infused’, more mergers and acquisitions and more and more news. Every day more articles and new revenue projection are released opining on what has happened, what is happening and what may happen. Perusing all this avalanche of info one common thread is obvious. The market will rise in 2019. There will be more product, more revenues, more infrastructure, more projections and more news. On such projection was made by Arcview Market Research, and was commented upon by various industry publications. One such summary said the following: “Global Marijuana Sales to Grow 38% to $16.9 Billion in 2019 Worldwide consumer cannabis spending should pick up big-time this year (2019) (in 20018) Canada had become the first industrialized country in the world to give the green light to recreational weed, paving the way for billions of dollars in legitimate annual sales, and pulling cannabis out of the shadows and into the spotlight as a valid business mode. We also witnessed plenty of history made in the U.S., too. In December, President Trump signed the farm bill into law, legalizing hemp and hemp-based cannabidiol products throughout the country. Roughly two-thirds of all states have now legalized medical cannabis, with 10 of those states also allowing adult consumption. Active companies in the industry making moves to ready that include: Choom(TM) Holdings Inc. (CSE:CHOO) (OTCQB:CHOOF), Fire & Flower Holdings Corp. (TSX-V: FAF) (OTCPK: FFLWF), National Access Cannabis Corp. (TSX-V: META.V) (OTCPK: NACNF), Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF), MedMen Enterprises Inc. (CSE: MMEN.CN) (OTCQX: MMNFF).
Cannabis’ mainstream appeal continues to grow, Wall Street has taken notice of the marijuana industry’s potential for quintupling, at minimum, in worldwide cannabis sales through 2029. Much of the increase in appeal is coming through the availability of cannabidiol (CBD) products, namely in the retail space. Major retailers and retail property owners are opening their doors to selling hemp-derived products from companies including Green Growth Brands (CSE:GGB) (OTC:GGBXF), Green Thumb Industries Inc. (OTC:GTBIF) (CSE:GTII), iAnthus Capital Holdings, Inc. (OTC:ITHUF) (CSE:IAN), Curaleaf Holdings, Inc. (OTC:CURLF) (CSE:CURA) and MedMen Enterprises Inc. (OTC:MMNFF) (CSE:MMEN).
: The cannabis industry presents a rare opportunity to profit from spectacular growth in a virtually untapped market.
The projections for the legal & CBD cannabis markets seem to get higher with every new arrival and big box and brick & mortar retailers of all sizes have taken notice. The legal marijuana and CBD markets numbers are increasingly optimistic. Legal Marijuana: “Today, the U.S. is the epicenter of the legal cannabis market and it appears it will hold that position for the foreseeable future. By 2022, legal cannabis revenue in the U.S. market is projected to hit $23.4 billion.” CBD: Add in the figures for the CBD markets: “Hemp-Derived CBD Will Outpace All Other Cannabis Markets, Projected to Hit $22 Billion by 2022” and it’s easy to see why retailers want ‘in’ on the market. The CBD market is easier right now for the big box companies to get involved especially since CBD for medical use is legal in 46 states and CBD derived from hemp rather than marijuana is legal in all states. Active companies in the cannabis industry includes: CROP INFRASTRUCTURE CORP. (CSE:CROP) (OTC:CRXPF), MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF), CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST), The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF).
Financialnewsmedia.com News Commentary
DENVER, Colo., April 15, 2019- (24/7MarketNews via COMTEX) Venture Market News for April 15, 2019.
With a total of 33 states so far approving medical marijuana, yet another state appears on the road to legal medical adoption. For the first time ever, the Kentucky legislative panel has advanced a medical marijuana bill.